NORTHERN TRUST CORP - THE ONCOLOGY INSTITUTE INC ownership

THE ONCOLOGY INSTITUTE INC's ticker is and the CUSIP is 68236X100. A total of 41 filers reported holding THE ONCOLOGY INSTITUTE INC in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
NORTHERN TRUST CORP ownership history of THE ONCOLOGY INSTITUTE INC
ValueSharesWeighting
Q3 2023$62,423
+135.8%
44,588
-7.3%
0.00%
Q2 2023$26,470
-85.1%
48,110
-81.7%
0.00%
Q1 2023$177,866
-58.1%
262,378
+1.9%
0.00%
Q4 2022$424,702
-64.1%
257,395
+0.8%
0.00%
Q3 2022$1,183,000
+62.3%
255,349
+77.4%
0.00%
Q2 2022$729,000
+465.1%
143,921
+696.7%
0.00%
Q1 2022$129,00018,0650.00%
Other shareholders
THE ONCOLOGY INSTITUTE INC shareholders Q4 2022
NameSharesValueWeighting ↓
Parian Global Management LP 444,244$3,167,0006.52%
Velan Capital Investment Management LP 600,000$4,278,0003.97%
Triatomic Management LP 428,100$3,052,0002.48%
Empery Asset Management, LP 70,733$504,0002.37%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,296,107$32,137,0000.72%
Redmile Group, LLC 2,414,432$17,215,0000.54%
Alpine Global Management, LLC 81,902$584,0000.07%
Saba Capital Management, L.P. 400,000$2,852,0000.04%
ExodusPoint Capital Management, LP 106,505$759,0000.01%
FMR LLC 12,000,000$85,560,0000.01%
View complete list of THE ONCOLOGY INSTITUTE INC shareholders